MC1R variants increase risk of melanomas harboring BRAF mutations

Journal of Investigative Dermatology

Volumn 128, Issue 10, 2008, Pages 2485-2490

  Fargnoli, Maria Concetia ^a   Pike, Kris ^b   Pfeiffer, Ruth M ^c   Tsang, Shirley ^b   Rozenblum, Ester ^b   Munroe, David J ^b   Golubeva, Yelena ^b   Calista, Donato ^d   Seidenari, Stefania ^e   Massi, Daniela ^f   Carli, Paolo ^f   Bauer, Juergen ^g   Elder, David E ^h   Bastian, Boris C ^g   Peris, Ketty ^a   Landi, Maria T ^c  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b SAIC FREDERICK INC   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d BUFALINI HOSPITAL   (Italy)

^e UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

^g UNIVERSITY OF CALIFORNIA   (United States)

^h UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; MELANOCORTIN 1 RECEPTOR;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER LOCALIZATION; CANCER RISK; CONTROLLED STUDY; EXON; FEMALE; GENE MUTATION; GENE SEQUENCE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN VARIANT; SKIN PIGMENTATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HAIR COLOR; HETEROZYGOTE; HUMANS; MALE; MELANOMA; MIDDLE AGED; MUTATION; NEOPLASMS, MULTIPLE PRIMARY; NEVUS; PROTO-ONCOGENE PROTEINS B-RAF; RECEPTOR, MELANOCORTIN, TYPE 1; SKIN NEOPLASMS; SUNLIGHT;

EID: 51749099797     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2008.67     Document Type: Article

References (19)

1. Beaumont KA, Shekar SL, Newton RA, James MR, Stow JL, Duffy DL et al. (2007) Receptor function, dominant negative activity and phenotype correlations for MC1R variant alleles. Hum Mol Genet 16:2249-60
2. Davies H, Bignell GR, Cox C, Stephens P, Edkins S, Clegg S et al. (2002) Mutations of the BRAF gene in human cancer. Nature 417:949-54
3. Duffy DL, Box NF, Chen W, Palmer JS, Montgomery GW, James MR et al. (2004) Interactive effects of MC1R and OCA2 on melanoma risk phenotypes. Hum Mol Genet 13:447-61
4. Dwyer T, Stankowich JM, Blizzard L, FitzGerald LM, Dickinson JL, Reilly A et al. (2004) Does the addition of the information on genotype improve prediction of the risk of melanoma and nonmelanoma skin cancer beyond that obtained from skin phenotype? Am J Epidemiol 159:826-33
5. Fargnoli MC, Altobelli E, Keller G, Chimenti S, Höfler H, Peris K (2006a) Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control study. Melanoma Res 16:175-82
6. Fargnoli MC, Spica T, Sera F, Pellacani G, Chiarugi A, Seidenari S et al. (2006b) Re: MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancer Inst 98:144-5
7. Fernandez LP, Milne RL, Bravo J, Avilés JA, Longo MI et al. (2007) MC1R: three novel variants identified in a malignant melanoma association study in the Spanish population. Carcinogenesis 28:1659-64
8. Gerstenblith MR, Goldstein AM, Fargnoli MC, Peris K, Landi MT (2007) Comprehensive evaluation of allele frequency differences of MC1R variants across populations. Hum Mutat 28:495-505
9. Kanetsky PA, Rebbeck TR, Hummer AJ, Panossian S, Armstrong BK, Kricker A et al. (2006) Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res 66:9330-7
10. Kennedy C, ter Huurne J, Berkhout M, Gruis N, Bastiaens M, Bergman W et al. (2001) Melanocortin 1 receptor (MC1R) gene variants are associated with an increased risk for cutaneous melanoma which is largely independent of skin type and hair color. J Invest Dermatol 117:294-300
11. Landi MT, Baccarelli A, Calista D, Pesatori A, Fears T, Tucker MA et al. (2001) Combined risk factors for melanoma in a Mediterranean population. Br J Cancer 85:1304-10
12. Landi MT, Bauer J, Pfeiffer RM, Elder DE, Hulley B, Minghetti P et al. (2006) MC1R germline variants confer risk for BRAF-mutant melanoma. Science 313:521-2
13. Landi MT, Kanetsky PA, Tsang S, Gold B, Munroe D, Rebbeck T et al. (2005) MC1R, ASIP, and DNA repair in sporadic and familial melanoma in a Mediterranean population. J Natl Cancet Inst 97:998-1007
14. Maldonado JL, Fridlyand J, Patel H, Jain AN, Busam K, Kageshita T et al. (2003) Determinants of BRAF mutations in primary melanomas. J Natl Cancer Inst 95:1878-90
15. Matichard E, Verpillat P, Meziani R, Gérard B, Descamps V, Legroux E et al. (2004) Melanocortin 1 receptor (MC1R) gene variants may increase the risk of melanoma in France independently of clinical risk factors and UV exposure. J Med Genet 41:e13
16. Palmer JS, Duffy DL, Box NF, Aitken JF, O'Gorman LE, Green AC et al. (2000) Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet 66:176-86
17. Rees JL (2004) The genetics of sun sensitivity in humans. Am J Hum Genet 75:739-51
18. Stratigos AJ, Dimisianos G, Nikolaou V, Poulou M, Sypsa V, Stefanaki I et al. (2006) Melanocortin receptor-1 gene polymorphisms and the risk of cutaneous melanoma in a low-risk southern European population. J Invest Dermatol 126:1842-9
19. Valverde P, Healy E, Sikkink S, Haldane F, Thody AJ, Carothers A et al. (1996) The Asp84Glu variant of the melanocortin 1 receptor (MC1R) is associated with melanoma. Hum Mol Genet 5:1663-6